<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=us-ascii">
<meta name="Generator" content="Microsoft Word 15 (filtered medium)">
<!--[if !mso]><style>v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style><![endif]--><style><!--
/* Font Definitions */
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0in;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:#0563C1;
text-decoration:underline;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
{mso-style-priority:34;
margin-top:0in;
margin-right:0in;
margin-bottom:8.0pt;
margin-left:.5in;
mso-add-space:auto;
line-height:105%;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParagraphCxSpFirst
{mso-style-priority:34;
mso-style-type:export-only;
margin-top:0in;
margin-right:0in;
margin-bottom:0in;
margin-left:.5in;
mso-add-space:auto;
line-height:105%;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListParagraphCxSpMiddle
{mso-style-priority:34;
mso-style-type:export-only;
margin-top:0in;
margin-right:0in;
margin-bottom:0in;
margin-left:.5in;
mso-add-space:auto;
line-height:105%;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagraphCxSpLast
{mso-style-priority:34;
mso-style-type:export-only;
margin-top:0in;
margin-right:0in;
margin-bottom:8.0pt;
margin-left:.5in;
mso-add-space:auto;
line-height:105%;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
span.EmailStyle17
{mso-style-type:personal-compose;
font-family:"Calibri",sans-serif;
color:windowtext;}
.MsoChpDefault
{mso-style-type:export-only;
font-family:"Calibri",sans-serif;}
@page WordSection1
{size:8.5in 11.0in;
margin:1.0in 1.0in 1.0in 1.0in;}
div.WordSection1
{page:WordSection1;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1027" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang="EN-US" link="#0563C1" vlink="#954F72" style="word-wrap:break-word">
<div class="WordSection1">
<p class="MsoNormal">Hi all,<o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal">In last Thursday’s SubPro meeting, we discussed Topic 9: Category 1 Safeguards – in particular, Recommendation 9.1, which reads, in part, as follows:
<b>“</b>Mandatory Public Interest Commitments (PICs) currently captured in Specification 11 3(a)-(d) of the Registry Agreement must continue to be included in Registry Agreements for gTLDs in subsequent procedures. …”<o:p></o:p></p>
<p class="MsoListParagraphCxSpFirst" style="mso-margin-top-alt:0in;margin-right:0in;margin-bottom:0in;margin-left:1.0in;mso-add-space:auto;line-height:normal">
<b><o:p> </o:p></b></p>
<p class="MsoListParagraphCxSpMiddle" style="margin:0in;mso-add-space:auto;line-height:normal">
The section in question was Specification 11 3(a):<o:p></o:p></p>
<p class="MsoListParagraphCxSpMiddle" style="margin:0in;mso-add-space:auto;line-height:normal">
<o:p> </o:p></p>
<p class="MsoListParagraphCxSpMiddle" style="margin-bottom:0in;mso-add-space:auto;line-height:normal">
<b>Specification 11 3(a)-(d): <o:p></o:p></b></p>
<p class="MsoListParagraphCxSpMiddle" style="margin-bottom:6.0pt;mso-add-space:auto;line-height:normal">
3. Registry Operator agrees to perform the following specific public interest commitments, which commitments shall be enforceable by ICANN and through the Public Interest Commitment Dispute Resolution Process . . .<o:p></o:p></p>
<p class="MsoListParagraphCxSpLast" style="margin-bottom:0in;mso-add-space:auto;line-height:normal">
(a) Registry Operator will include a provision in its Registry-Registrar Agreement that requires Registrars to include in their Registration Agreements a provision prohibiting Registered Name Holders from distributing malware, abusively operating botnets, phishing,
piracy, trademark or copyright infringement, fraudulent or deceptive practices, counterfeiting or otherwise engaging in activity contrary to applicable law, and providing (consistent with applicable law and any related procedures) consequences for such activities
including suspension of the domain name. <o:p></o:p></p>
<p class="MsoNormal"><span style="color:black"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="color:black">As we discussed in the meeting, Specification 11 3(a) as currently written falls short of its intended purpose, protecting end users. It is therefore necessary to revise Specification 11 3(a) to hold new TLDs that
are subject to Category 1 Safeguards accountable for their registrants’ contractual compliance with those safeguards. Existing TLDs could be grandfathered as exempt from the Specification 11 3(a) revision.<o:p></o:p></span></p>
<p class="MsoNormal"><span style="color:black"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="color:black">It seems there was some interest among the working group members to further explore this idea.<o:p></o:p></span></p>
<p class="MsoNormal"><span style="color:black"><o:p> </o:p></span></p>
<p class="MsoNormal" style="margin-bottom:6.0pt"><span style="color:black">I would propose changing Recommendation 9.1 in the final report to add the underlined text below:<o:p></o:p></span></p>
<p class="MsoNormal"><b>“</b>Mandatory Public Interest Commitments (PICs) currently captured in Specification 11 3(a)-(d) of the Registry Agreement must continue to be included in Registry Agreements for gTLDs in subsequent procedures.”
<u>In addition, Specification 11 3(a) should be revised <span style="color:black">
to hold new TLDs that are subject to Category 1 Safeguards accountable for their registrants’ contractual compliance with those safeguards. Existing TLDs could be grandfathered as exempt from the Specification 11 3(a) revision.</span></u><span style="color:black"><o:p></o:p></span></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal">I’d be interested to hear others’ thoughts.<o:p></o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal">Thanks,<o:p></o:p></p>
<p class="MsoNormal">Gg<o:p></o:p></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt"><o:p> </o:p></span></b></p>
<p class="MsoNormal"><b><span style="font-size:12.0pt">Gertrude “Gg” Levine</span></b><span style="font-size:12.0pt;color:red"><o:p></o:p></span></p>
<p class="MsoNormal">Digital Health Manager<o:p></o:p></p>
<p class="MsoNormal" style="margin-bottom:12.0pt">847/391-4497<o:p></o:p></p>
<p class="MsoNormal" style="margin-top:.25in"><!--[if gte vml 1]><v:shapetype id="_x0000_t75" coordsize="21600,21600" o:spt="75" o:preferrelative="t" path="m@4@5l@4@11@9@11@9@5xe" filled="f" stroked="f">
<v:stroke joinstyle="miter" />
<v:formulas>
<v:f eqn="if lineDrawn pixelLineWidth 0" />
<v:f eqn="sum @0 1 0" />
<v:f eqn="sum 0 0 @1" />
<v:f eqn="prod @2 1 2" />
<v:f eqn="prod @3 21600 pixelWidth" />
<v:f eqn="prod @3 21600 pixelHeight" />
<v:f eqn="sum @0 0 1" />
<v:f eqn="prod @6 1 2" />
<v:f eqn="prod @7 21600 pixelWidth" />
<v:f eqn="sum @8 21600 0" />
<v:f eqn="prod @7 21600 pixelHeight" />
<v:f eqn="sum @10 21600 0" />
</v:formulas>
<v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect" />
<o:lock v:ext="edit" aspectratio="t" />
</v:shapetype><v:shape id="Picture_x0020_1" o:spid="_x0000_s1026" type="#_x0000_t75" style='position:absolute;margin-left:0;margin-top:101.55pt;width:77.05pt;height:86.45pt;z-index:251658240;visibility:visible;mso-wrap-style:square;mso-width-percent:0;mso-height-percent:0;mso-wrap-distance-left:0;mso-wrap-distance-top:0;mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;mso-position-horizontal:left;mso-position-horizontal-relative:text;mso-position-vertical:absolute;mso-position-vertical-relative:text;mso-width-percent:0;mso-height-percent:0;mso-width-relative:margin;mso-height-relative:page'>
<v:imagedata src="cid:image001.png@01D6BC2D.DF198470" o:title="" croptop="2621f" cropbottom="2621f" cropleft="5767f" cropright="5767f" />
<w:wrap type="square"/>
</v:shape><![endif]--><![if !vml]><img width="103" height="115" style="width:1.0729in;height:1.1979in" src="cid:image002.png@01D6BC2D.DF198470" align="left" hspace="6" style="margin-left:-6px;margin-right:6px" v:shapes="Picture_x0020_1"><![endif]><b><span style="font-size:14.0pt">National
Association of Boards of Pharmacy<o:p></o:p></span></b></p>
<p class="MsoNormal"><span style="color:black">1600 Feehanville Dr, Mount Prospect, IL 60056<o:p></o:p></span></p>
<p class="MsoNormal"><a href="http://www.nabp.pharmacy/"><span style="color:blue">www.nabp.pharmacy</span></a> |
<u><a href="mailto:glevine@nabp.pharmacy">glevine@nabp.pharmacy</a></u><o:p></o:p></p>
<table class="MsoNormalTable" border="0" cellspacing="0" cellpadding="0" style="margin-left:-5.4pt;border-collapse:collapse">
<tbody>
<tr style="height:31.95pt">
<td width="45" style="width:34.05pt;padding:0in 5.4pt 0in 5.4pt;height:31.95pt">
<p class="MsoNormal"><a href="https://www.facebook.com/NABP1904/"><span style="color:windowtext;text-decoration:none"><img border="0" width="31" height="31" style="width:.3229in;height:.3229in" id="Picture_x0020_7" src="cid:image003.png@01D6BC2D.DF198470"></span></a><o:p></o:p></p>
</td>
<td width="45" style="width:34.05pt;padding:0in 5.4pt 0in 5.4pt;height:31.95pt">
<p class="MsoNormal"><a href="https://twitter.com/nabp"><span style="color:windowtext;text-decoration:none"><img border="0" width="31" height="31" style="width:.3229in;height:.3229in" id="Picture_x0020_8" src="cid:image004.png@01D6BC2D.DF198470"></span></a><o:p></o:p></p>
</td>
<td width="45" style="width:34.05pt;padding:0in 5.4pt 0in 5.4pt;height:31.95pt">
<p class="MsoNormal"><a href="https://www.linkedin.com/company/national-association-of-boards-of-pharmacy/"><span style="color:windowtext;text-decoration:none"><img border="0" width="31" height="31" style="width:.3229in;height:.3229in" id="Picture_x0020_9" src="cid:image005.png@01D6BC2D.DF198470"></span></a><o:p></o:p></p>
</td>
<td width="45" style="width:34.05pt;padding:0in 5.4pt 0in 5.4pt;height:31.95pt">
<p class="MsoNormal"><a href="https://www.youtube.com/c/NationalAssociationofBoardsofPharmacy"><span style="color:windowtext;text-decoration:none"><img border="0" width="31" height="31" style="width:.3229in;height:.3229in" id="Picture_x0020_10" src="cid:image006.png@01D6BC2D.DF198470"></span></a><o:p></o:p></p>
</td>
</tr>
</tbody>
</table>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><o:p> </o:p></p>
</div>
</body>
</html>